PubMed Health⌕ Search

Biomedical subjects

P Wooldridge

Publications and source records attributed to P Wooldridge.

6 recordsLinked to original sources

Development of a tool to measure therapeutic factors in group process.

A tool, the Therapeutic Group Interaction Factors Scale (TGIF), was developed for systematically and objectively measuring the extent to which therapeutic factors defined by Yalom are present or absent in group process. Preliminary findings suggest that the TGIF is relatively easy to learn and use by coders who are familiar with Yalom's work. Once this tool has been further developed and tested, it will permit nurses and other therapists who lead/facilitate therapeutic groups to study the relationship between Yalom's factors and therapeutic outcomes objectively, rather than by asking patients to evaluate the contribution of each factor subjectively.

Group Processes↗

Home safety & older adults.

Home care workers are in a prime position to identify personal and environmental risk factors for seniors living at home. This article identifies many of these risks and offers a logical approach to alleviating some of them.

Accidents, Home↗

Dignity--the cornerstone of care.

At the Alzheimer's Day Center in Columbia, South Carolina, staff, families, and volunteers comprise the A-team. The team offers persons with Alzheimer's disease a homelike environment full of laughter and love, while providing respite for family caregivers.

Aged↗

Early sibling attachment.

A sample of 30 predominantly three- and four-year-old siblings were videotaped during their first meeting with a new sibling at the time of the mother's discharge from the hospital. The first five minutes of interaction were divided into 20, 15-second intervals, and each interval was coded for the presence or absence of 28 behaviors believed to be related to the early attachment process. The exploration behaviors of siblings showed considerable uniformity. The sibling's age, sex, or participation in sibling preparation classes produced no marked differences in behavior. Recommendations are made for further research.

Attention↗

Effect of infusing fat emulsion into extracorporeal membrane oxygenation circuits.

Our objectives were to identify problems associated with the administration of fat emulsion by extracorporeal membrane oxygenation (ECMO) circuits, and gather information from other institutions on standards of practice and the complications associated with infusion of fat emulsion by ECMO to infants and children. In vitro analysis was performed using six circuits. Fat emulsion was infused into a prereservoir port at 3 ml/hour. Circuits and blood samples collected distal to the oxygenator were inspected visually for layering (separation of fat emulsion from blood), agglutination, and phase separation (formation of an oil layer) at 0.5, 1, 2, 4, 6, 12, and 24 hours. At 24 hours, samples were reevaluated and circuits dissected. All circuits showed layering and agglutination. Blood clots were present in five circuits during the simulation. There was no evidence of phase separation in the samples. Adhesion of emulsion to the equipment was present in all circuits. Five of the membrane oxygenators contained clots. One contained long strands of fat; separation of its mesh revealed an oily residue indicating disruption of the stability of the emulsion. Survey responses from 54 centers found that 78% used fat emulsion routinely in neonatal or pediatric patients receiving ECMO. Most used both ECMO and separate venous access for the infusion, depending on availability. Twenty-two (52%) of the 42 centers using fat emulsion had a policy in place regarding site selection. Of those, 73% preferred central venous access, another 18% used a prereservoir port of the ECMO circuit. The most frequently reported problems with administration through the circuit were cracking of stopcocks, clogging and malfunction of the membrane oxygenator, agglutination of the emulsion, and increase in blood clot formation. Our results suggest that fat emulsion should be infused through a separate intravenous site whenever possible. Based on these results and current practices of most ECMO centers, a clinical trial is currently being conducted to provide additional information.

Blood Coagulation↗